The prognostic impact of age in different molecular subtypes of breast cancer.
about
The prognostic value of age for invasive lobular breast cancer depending on estrogen receptor and progesterone receptor-defined subtypes: A NCDB analysisNew insights into the prognostic value of Ki-67 labeling index in patients with triple-negative breast cancerConditional disease-free survival among patients with breast cancer.Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway.Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study.Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society.Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis.The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.Association between changes in body fat and disease progression after breast cancer surgery is moderated by menopausal status.YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways.Intratumor heterogeneity predicts metastasis of triple-negative breast cancer.A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen.Fibrotic focus: An important parameter for accurate prediction of a high level of tumor-associated macrophage infiltration in invasive ductal carcinoma of the breast.Metastatic and triple-negative breast cancer: challenges and treatment optionsBranched rolling circle amplification method for measuring serum circulating microRNA levels for early breast cancer detection
P2860
Q36905846-66BDA632-E34A-4C84-8870-ADC910B7A78DQ37269463-AC7737D2-C269-4F54-8967-9BC64DDDCA47Q37582617-3B18C249-45D0-4850-B20B-031CD78810DEQ37645090-CF11B5EF-4182-4D91-BA64-594B4D7A954DQ38380655-68AB4538-E47D-475B-8404-BC55E08D489BQ38399507-FC896812-7A8A-4FC6-8004-CC7231D35BB6Q38611108-3694BD83-E86D-4DD7-87EA-D119BC3EB20AQ38679395-446C4093-6965-44DE-85E6-3ADA32456FCAQ47102767-2A891DD8-13A2-43CC-AC71-249BB8403351Q47153328-5236A455-4BAB-4A89-ADD5-EBC681EAA1FAQ47801879-163DDD8D-D7A4-449C-9B24-FEA5804A0A34Q49912442-AD715182-042E-44AA-B21E-AA44C06BAE4FQ50955504-B528303A-B4A5-4095-8038-54922C51E290Q57105258-3E5A39CE-596F-4449-B5CC-99050E22D029Q58733916-44D91997-D692-4D7D-9E64-107D6A8BFE48
P2860
The prognostic impact of age in different molecular subtypes of breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The prognostic impact of age in different molecular subtypes of breast cancer.
@en
type
label
The prognostic impact of age in different molecular subtypes of breast cancer.
@en
prefLabel
The prognostic impact of age in different molecular subtypes of breast cancer.
@en
P2093
P2860
P1476
The prognostic impact of age in different molecular subtypes of breast cancer.
@en
P2093
Achim Rody
Cornelia Liedtke
Daniel Beyer
Eva-Beatrice Kohls
Kerstin Lausen
Kristin Baumann
Lars Hanker
Sven Becker
Uwe Holtrich
P2860
P2888
P304
P356
10.1007/S10549-015-3491-3
P407
P50
P577
2015-07-21T00:00:00Z
P6179
1046056274